Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

Vaccines, Free Full-Text

PDF) Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation

Frontiers Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study - The Lancet Haematology

Pathogens, Free Full-Text

Efficacy and risk of mRNA vaccination in patients with autoimmune inflammatory rheumatic diseases, Inflammation and Regeneration

COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies

Peptides for Vaccine Development

Capturing adaptive immunity against SARS-CoV-2 in patients with cancer

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies

Frontiers Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents